NovoCure NVCR Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from NovoCure’s reported figures.
Based on trailing twelve months.
The official record: NovoCure’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about NovoCure's free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is NovoCure's free cash flow margin?
- NovoCure (NVCR) reported free cash flow margin of -7.1% in Q1 2026.
- How has NovoCure's free cash flow margin changed year-over-year?
- NovoCure's free cash flow margin increased by 38.6% year-over-year, from -11.6% to -7.1%.
- What is the long-term trend for NovoCure's free cash flow margin?
- Over 4 years (2020 to 2025), NovoCure's free cash flow margin has grown at a -9.3% compound annual growth rate (CAGR), from 17% to -11.5%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.